MSN, Sandoz Settle Sunovion's IP Suit Over Latuda Generics
A New Jersey federal judge Thursday dismissed Sunovion Pharmaceuticals Inc.'s patent infringement suit against MSN Laboratories and Sandoz Inc. over its bipolar medication Latuda after the parties reached a deal and...To view the full article, register now.
Already a subscriber? Click here to view full article